|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/404 | |||
| A61P 31/14 |
| (11) | Number of the document | 2416765 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10714126.9 |
| Date of filing the European patent application | 2010-04-05 | |
| (97) | Date of publication of the European application | 2012-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/029933 |
| Date | 2010-04-05 |
| (87) | Number | WO 2010/117939 |
| Date | 2010-10-14 |
| (30) | Number | Date | Country code |
| 166922 P | 2009-04-06 | US |
| (72) |
LAHSER, Frederick, C., US
GU, Zhengxian, US
|
| (73) |
PTC Therapeutics, Inc.,
100 Corporate Court,, South Plainfield, NJ 07080,
US
|
| (54) | HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS |
| HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS |